Platelets as a prognostic marker for sepsis: A cohort study from the MIMIC-III database.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
06 Nov 2020
Historique:
entrez: 7 11 2020
pubmed: 8 11 2020
medline: 26 11 2020
Statut: ppublish

Résumé

During sepsis, platelets dysfunction contributes to organ dysfunction. Studies on platelets dysfunction in the long-term prognosis of sepsis are lacking. The aim of this study was to assess the role of platelets in the long-term prognosis of sepsis patients.A total of 4576 sepsis patients were extracted from MIMIC III Database. Survival was analyzed by the Kaplan-Meier method. Univariate and multivariate cox analyses were performed to identify prognostic factors. Significant prognostic factors were combined to build a nomogram to predict 1 year overall survival (OS). The discriminative ability and predictive accuracy of the nomogram were evaluated using the receiver operating characteristic curve (ROC) analysis and calibration curves used for sepsis.The more abnormal the platelet level, the worse prognosis of patients. After final regression analysis, age, blood urea nitrogen, platelets, international normalized ratio, partial thromboplastin time, potassium, hemoglobin, white blood cell count, organ failures were found to be independent predictors of 1 year OS of sepsis patient and were entered into a nomogram. The nomogram showed a robust discrimination, with an area under the receiver operating characteristic curve of 0.752. The calibration curves for the probability of the prognosis of sepsis patients showed optimal agreement between the probability as predicted by the nomogram and the actual probability.Platelet was an independent prognostic predictor of 1 year OS for patients with sepsis. Platelet-related nomogram that can predict the 1 year OS of sepsis patients. It revealed optimal discrimination and calibration, indicating that the nomogram may have clinical utility.

Identifiants

pubmed: 33157998
doi: 10.1097/MD.0000000000023151
pii: 00005792-202011060-00092
pmc: PMC7647525
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e23151

Références

J Transl Med. 2018 Jul 18;16(1):199
pubmed: 30021591
Int J Mol Sci. 2017 Oct 20;18(10):
pubmed: 29053592
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Exp Ther Med. 2020 Feb;19(2):1251-1258
pubmed: 32010296
Thromb Haemost. 2009 Mar;101(3):439-51
pubmed: 19277403
Ann Am Thorac Soc. 2015 Feb;12(2):216-20
pubmed: 25569845
Crit Care. 2007;11(6):R120
pubmed: 17996049
N Engl J Med. 2003 Apr 17;348(16):1546-54
pubmed: 12700374
Chest. 2011 Mar;139(3):658-668
pubmed: 21362652
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Lancet Oncol. 2015 Apr;16(4):e173-80
pubmed: 25846097
Am J Med. 1976 Nov;61(5):585-9
pubmed: 984062
N Engl J Med. 2017 Aug 3;377(5):414-417
pubmed: 28658587
Thromb Res. 2019 Jul;179:56-63
pubmed: 31078121
J Crit Care. 2014 Jun;29(3):362-6
pubmed: 24405656
J Leukoc Biol. 2008 Mar;83(3):536-45
pubmed: 18032692
FASEB J. 2001 Nov;15(13):2337-44
pubmed: 11689459
PLoS One. 2015 Mar 30;10(3):e0120641
pubmed: 25822778
J Crit Care. 2014 Oct;29(5):885.e1-6
pubmed: 24895093
Mediators Inflamm. 2012;2012:390892
pubmed: 22577249
Glob J Health Sci. 2015 Jul 28;8(3):193-8
pubmed: 26493432
Basic Res Cardiol. 2010 Sep;105(5):609-20
pubmed: 20467749
Int J Mol Sci. 2019 Oct 29;20(21):
pubmed: 31671729
Chin Med J (Engl). 2015 Aug 5;128(15):2012-8
pubmed: 26228211
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Sci Data. 2016 May 24;3:160035
pubmed: 27219127
J Thromb Haemost. 2011 Sep;9(9):1795-803
pubmed: 21711444
BMC Infect Dis. 2019 Sep 6;19(1):780
pubmed: 31492102
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292
Int J Cardiol. 2019 Jan 1;274:214-220
pubmed: 30072155
Kidney Int. 2016 Mar;89(3):555-64
pubmed: 26880452
J Clin Invest. 2006 Dec;116(12):3211-9
pubmed: 17143330

Auteurs

Lina Zhao (L)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Lijiao Zhao (L)

Department of Pharmaceutical Engineering, Inner Mongolia Agricultural University, Hohhot.

Yun Ying Wang (YY)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Fei Yang (F)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Zhuang Chen (Z)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Qing Yu (Q)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Hui Shi (H)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Shiying Huang (S)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Xiaoli Zhao (X)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Limei Xiu (L)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Xiaolu Li (X)

Department of Critical Care Medicine, Chifeng Municipal Hospital, Inner Mongolia.

Yun Li (Y)

Department of Anesthesiology Medicine, Chifeng Municipal Hospital, Inner Mongolia, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH